| Bridgehead
Consulting can draw on a wide range of skills and experience,
including direct experience from both a company and a payer
perspective, to advise companies in all stages of product
development and commercialisation.
Services range from initial market assessments focusing on
pricing and reimbursement potential and risks, through the
development of value messages to meet the concerns of payers
and budget holders, to the formulation of pricing and reimbursement
strategies and supporting clients through their implementation.
Bridgehead Consulting uses a variety of
methodologies and techniques, including the creation of therapy
and market specific funding and patient flow maps, reviews
of the available information and arguments from a payer perspective,
payer discussion programmes, qualitative and quantitative
pricing studies, modelling of parallel trade risks and optimal
launch sequences by market and the creation of both generic
and market specific reimbursement support dossiers.
Further
information |
|
To discuss
your requirements please contact
us on
|
| |
|
|
Examples
of recent projects include: |
-
Pricing strategy for a novel bio-analytical
instrumentation system
-
Pricing strategy for an early
stage oncology therapy
-
Pricing survey of cancer therapies
in Europe and the US for a European biotech company
-
General advice on European pricing
strategy and parallel trade issues for a US based
company
-
Pricing assessment and preliminary
pricing strategy for an innovative NCE for a UK-based
biotechnology company
-
Overview of global pricing and
reimbursement systems for a national industry association
-
Advice on reimbursement dossier
development and negotiation strategies in Europe
for a key strategic product from a global pharmeceutical
company
|
| |
Case
studies (click to view) |
|
|
| |
|
